These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3265770)

  • 1. The neurotoxicant MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) increases glial fibrillary acidic protein and decreases dopamine levels of the mouse striatum: evidence for glial response to injury.
    Reinhard JF; Miller DB; O'Callaghan JP
    Neurosci Lett; 1988 Dec; 95(1-3):246-51. PubMed ID: 3265770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the origins of astrocyte response to injury using the dopaminergic neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    O'Callaghan JP; Miller DB; Reinhard JF
    Brain Res; 1990 Jun; 521(1-2):73-80. PubMed ID: 1976416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astrocyte responses to dopaminergic denervations by 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as evidenced by glial fibrillary acidic protein immunohistochemistry.
    Strömberg I; Björklund H; Dahl D; Jonsson G; Sundström E; Olson L
    Brain Res Bull; 1986 Aug; 17(2):225-36. PubMed ID: 3094835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced damage of striatal dopaminergic fibers attenuates subsequent astrocyte response to MPTP.
    O'Callaghan JP; Miller DB; Reinhard JF
    Neurosci Lett; 1990 Sep; 117(1-2):228-33. PubMed ID: 1981254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diethyldithiocarbamate potentiates the neurotoxicity of in vivo 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and of in vitro 1-methyl-4-phenylpyridinium.
    Miller DB; Reinhard JF; Daniels AJ; O'Callaghan JP
    J Neurochem; 1991 Aug; 57(2):541-9. PubMed ID: 1649252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel anti-Parkinsonian agent, zonisamide, attenuates MPTP-induced neurotoxicity in mice.
    Yano R; Yokoyama H; Kuroiwa H; Kato H; Araki T
    J Mol Neurosci; 2009 Sep; 39(1-2):211-9. PubMed ID: 19199078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Riluzole (2-amino-6-trifluoromethoxy benzothiazole) attenuates MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice.
    Araki T; Muramatsu Y; Tanaka K; Matsubara M; Imai Y
    Neurosci Lett; 2001 Oct; 312(1):50-4. PubMed ID: 11578843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal and astroglial responses to the serotonin and norepinephrine neurotoxin: 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine.
    Luellen BA; Miller DB; Chisnell AC; Murphy DL; O'Callaghan JP; Andrews AM
    J Pharmacol Exp Ther; 2003 Dec; 307(3):923-31. PubMed ID: 14561848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine pretreatment attenuates methamphetamine-induced dopamine toxicity.
    Kita T; Saraya T; Konishi N; Matsunari Y; Shimada K; Nakamura M; O'Hara K; Wagner GC; Nakashima T
    Pharmacol Toxicol; 2003 Feb; 92(2):71-80. PubMed ID: 12747576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced astrogliosis does not require activation of ornithine decarboxylase.
    O'Callaghan JP; Seidler FJ
    Neurosci Lett; 1992 Dec; 148(1-2):105-8. PubMed ID: 1300481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGF-2 in the MPTP model of Parkinson's disease: effects on astroglial cells.
    Otto D; Unsicker K
    Glia; 1994 May; 11(1):47-56. PubMed ID: 8070894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of dopaminergic neurons with a novel astrocyte modulating agent (R)-(-)-2-propyloctanoic acid (ONO-2506) in an MPTP-mouse model of Parkinson's disease.
    Kato H; Araki T; Imai Y; Takahashi A; Itoyama Y
    J Neurol Sci; 2003 Apr; 208(1-2):9-15. PubMed ID: 12639719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astrocytic responses to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in cat and mouse brain.
    Schneider JS; Denaro FJ
    J Neuropathol Exp Neurol; 1988 Jul; 47(4):452-8. PubMed ID: 2898510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The MAP kinase cascade is activated prior to the induction of gliosis in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of dopaminergic neurotoxicity.
    O'Callaghan JP; Martin PM; Mass MJ
    Ann N Y Acad Sci; 1998 May; 844():40-9. PubMed ID: 9668663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation by reserpine and tetrabenazine of brain catecholamine depletions by MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) in the mouse; evidence for subcellular sequestration as basis for cellular resistance to the toxicant.
    Reinhard JF; Daniels AJ; Viveros OH
    Neurosci Lett; 1988 Aug; 90(3):349-53. PubMed ID: 3262206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed treatment with arundic acid reduces the MPTP-induced neurotoxicity in mice.
    Oki C; Watanabe Y; Yokoyama H; Shimoda T; Kato H; Araki T
    Cell Mol Neurobiol; 2008 May; 28(3):417-30. PubMed ID: 18204968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sex and gonadectomy on brain MPTP toxicity and response to dutasteride treatment in mice.
    Isenbrandt A; Morissette M; Bourque M; Lamontagne-Proulx J; Coulombe K; Soulet D; Di Paolo T
    Neuropharmacology; 2021 Dec; 201():108784. PubMed ID: 34555366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral alterations in a MPTP-mouse model of Parkinson's disease--an immunocytochemical study.
    Muramatsu Y; Kurosaki R; Watanabe H; Michimata M; Matsubara M; Imai Y; Araki T
    J Neural Transm (Vienna); 2003 Oct; 110(10):1129-44. PubMed ID: 14523625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Manganese does not alter the severe neurotoxicity of MPTP.
    Baek SY; Kim YH; Oh SO; Lee CR; Yoo CI; Lee JH; Lee H; Sim CS; Park J; Kim JW; Yoon CS; Kim Y
    Hum Exp Toxicol; 2007 Mar; 26(3):203-11. PubMed ID: 17439923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Connexin 30 deficiency attenuates A2 astrocyte responses and induces severe neurodegeneration in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride Parkinson's disease animal model.
    Fujita A; Yamaguchi H; Yamasaki R; Cui Y; Matsuoka Y; Yamada KI; Kira JI
    J Neuroinflammation; 2018 Aug; 15(1):227. PubMed ID: 30103794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.